Zhongnan Medical Journal Press

Home Results

A total of 4 result was found. Results that relate to WEI Anhua

Pharmacoeconomic evaluation of glucagon-like peptide-1 receptor agonist combined with metformin in the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):388-401.
1298 times 965 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide-1 receptor agonist Metformin Type 2 diabetes mellitus Cost-utility Markov model Pharmacoeconomics
Details
Efficacy and safety of glucagon-like peptide 1 receptor agonists in the treatment of overweight or obese patients with type 2 diabetes: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):519-538.
1431 times 451 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide 1 receptor agonists Type 2 diabetes mellitus Obesity or overweight Efficacy Safety Meta-analysis Randomized controlled trial
Details
Research on signal mining of adverse event of minocycline based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(6):632-641.
1418 times 462 times

ZENG Lu WANG Lu WEI Anhua ZHOU Lumin

Minocycline FAERS database Adverse drug event Data mining Pharmacovigilence
Details
Edaravone in the treatment of acute ischemic stroke: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1147-1155.
311 times 59 times

YU Fang ZENG Lu WEI Anhua GONG Xuepeng WANG Lu

Edaravone Acute ischemic stroke Efficacy Safety Economy Rapid health technology assessment
Details